Sonendo, Inc. SONX
We take great care to ensure that the data presented and summarized in this overview for Sonendo, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding SONX
View all-
First Light Asset Management, LLC Edina, MN5.89MShares$12.4 Million0.02% of portfolio
-
Meritech Capital Associates Iv, L.L.C. Palo Alto, CA1.47MShares$3.1 Million3.03% of portfolio
-
Parallel Advisors, LLC350KShares$738,5000.0% of portfolio
-
Farther Finance Advisors, LLC San Francisco, CA75KShares$158,2500.0% of portfolio
Latest Institutional Activity in SONX
Top Purchases
Top Sells
About SONX
Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment device for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of EDTA that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for dental practitioners. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. Sonendo, Inc. was incorporated in 2006 and is headquartered in Laguna Hills, California.
Insider Transactions at SONX
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 17
2024
|
John J. Bostjancic Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
600,000
+31.25%
|
-
|
|
Sep 17
2024
|
John P. Mc Gaugh Sr. VP Operations |
BUY
Grant, award, or other acquisition
|
Direct |
500,000
+36.96%
|
-
|
|
Sep 17
2024
|
Carolyn Beaver |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+43.22%
|
-
|
|
Sep 17
2024
|
Vamsi Mohan Raj Pudipeddi |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+7.21%
|
-
|
|
Sep 17
2024
|
Bjarne Bergheim President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,600,000
+31.44%
|
-
|
|
Sep 17
2024
|
Anthony P Bihl Iii |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+38.02%
|
-
|
|
Sep 17
2024
|
Olav Bergheim |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+8.54%
|
-
|
|
Jun 21
2024
|
Bjarne Bergheim President and CEO |
SELL
Open market or private sale
|
Direct |
43,240
-2.24%
|
$0
$0.09 P/Share
|
|
Jun 20
2024
|
Roy T Chen Chief Talent Officer |
SELL
Open market or private sale
|
Direct |
8,510
-3.51%
|
$0
$0.09 P/Share
|
|
Jun 05
2024
|
John J. Bostjancic Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
720,000
+50.0%
|
-
|
|
May 23
2024
|
John P. Mc Gaugh Sr. VP Operations |
SELL
Open market or private sale
|
Direct |
10,901
-3.0%
|
$0
$0.09 P/Share
|
|
May 22
2024
|
John P. Mc Gaugh Sr. VP Operations |
BUY
Open market or private purchase
|
Direct |
116,500
+24.26%
|
$0
$0.1 P/Share
|
|
May 16
2024
|
Olav Bergheim |
BUY
Open market or private purchase
|
Indirect |
520,000
+21.13%
|
$0
$0.1 P/Share
|
|
May 14
2024
|
Vamsi Mohan Raj Pudipeddi |
BUY
Open market or private purchase
|
Direct |
500,000
+17.39%
|
$0
$0.09 P/Share
|
|
May 06
2024
|
Chris Guo Interim CFO |
SELL
Open market or private sale
|
Direct |
492
-0.96%
|
$0
$0.1 P/Share
|
|
May 03
2024
|
Roy T Chen Chief Talent Officer |
SELL
Open market or private sale
|
Direct |
774
-0.32%
|
$0
$0.09 P/Share
|
|
May 03
2024
|
Bjarne Bergheim President and CEO |
SELL
Open market or private sale
|
Direct |
2,381
-0.12%
|
$0
$0.09 P/Share
|
|
Apr 15
2024
|
Chris Guo Interim CFO |
SELL
Open market or private sale
|
Direct |
481
-0.93%
|
$0
$0.08 P/Share
|
|
Mar 26
2024
|
Bjarne Bergheim President and CEO |
SELL
Open market or private sale
|
Direct |
11,493
-0.59%
|
$0
$0.1 P/Share
|
|
Mar 26
2024
|
Roy T Chen Chief Talent Officer |
SELL
Open market or private sale
|
Direct |
2,625
-1.07%
|
$0
$0.1 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 4.22M shares |
|---|---|
| Open market or private purchase | 3.11M shares |
| Payment of exercise price or tax liability | 39.2K shares |
|---|---|
| Open market or private sale | 187K shares |